Consolidated Statements of Cash Flows - USD ($)	8 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net increase (decrease) in net assets resulting from operations	$ 2,314,546	$ 18,771,553	$ 9,993,933
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided (used in) operating activities:
Net realized (gain) loss on investments	(240,492)	(45,283)	(43,607)
Net change in unrealized (gain) loss on investments	(67,642)	3,449,646	817,733
Net accretion of discounts and amortization of premiums	(101,958)	(1,382,244)	(862,570)
Purchases of investments	(63,820,333)	(90,635,833)	(217,512,647)
Proceeds from sales of investments	844,010	2,679,712	7,971,150
Proceeds from principal payments	2,559,788	15,101,932	10,026,750
Amortization of deferred financing costs	37,131	627,611	440,322
Payment-in-kind interest income	(249,427)	(3,189,791)	(495,426)
Changes in operating assets and liabilities:
Interest receivable	(419,381)	(418,765)	(2,242,657)
Carried interest payable	(990,732)	0	0
Management fees payable, net of fee waivers (Note 6)	757,520	71,420	292,472
Incentive fees payable, net of fee waivers (Note 6)	225,883	3,961,476	(225,883)
Credit facility interest payable	172,096	1,362,066	2,111,450
Other payables	107,127	181,769	46,821
Professional fees payable	117,959	113,061	83,824
Due to Shareholder	(413,685)	0	0
Legal fees payable	(25,132)	585	1,245
Reimbursement expense payable	0	43,193	35,877
Net cash provided by (used in) operating activities	(59,192,722)	(49,307,892)	(189,561,213)
Cash flows from financing activities:
Proceeds from issuance of common shares, including subscriptions received in advance	41,634,310	38,647,846	95,480,355
Redemption of common shares	(13,923,154)	0	0
Payments in repurchase of shares	0	(16,552,049)	(2,564,753)
Proceeds from credit facility	35,000,000	96,000,000	188,000,000
Repayments of credit facility	(1,000,000)	(72,500,000)	(69,000,000)
Distributions paid	(318,792)	(10,200,810)	(4,263,621)
Deferred financing and debt issuance costs paid	(328,350)	0	(1,623,630)
Net cash provided by (used in) financing activities	61,064,014	35,394,987	206,028,351
Net increase (decrease) in Cash	1,871,292	(13,912,905)	16,467,138
Cash, beginning of period	620,015	18,958,445	2,491,307
Cash, end of period	2,491,307	5,045,540	18,958,445
Non cash operating activities:
Transfer of investments (see Note 1)	(42,865,258)	0	0
Transfer of cash (see Note 1)	(620,015)	0	0
Transfer of carried interest payable (see Note 1)	990,732	0	0
Transfer of organizational costs payable (see Note 1)	413,685	0	0
Transfer of other receivables and payables (see Note 1)	(134,173)	0	0
Interest received in kind	249,427	3,189,791	495,426
Supplemental and non cash financing activities:
Shares issued from BDC conversion (see Note 1)	42,215,029	0	0
Shares issued from dividend reinvestment plan (see Note 10)	445,927	10,177,951	3,345,327
Supplemental Information:
Cash paid for interest	$ 13,586	$ 10,626,030	$ 2,731,891